EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Biomarkers of post-stroke cognitive impairment—a systematic literature review

Biomarker des post-stroke kognitiven Defizits – systematische Literaturübersicht

Lars Schmidli, Ines Richter, Shilpa Thaliyath, Johannes Frenger, Annaelle Zietz, Johannes Teller, Ramona Schuppner, Johanna Ernst, Maria M Gabriel, Pol Camps-Renom, John McCabe, Steffen Tiedt und 3 weitere

Frontiers in Behavioral Neuroscience · 22.06.2026 · 20

DOI: 10.3389/fnbeh.2026.1864277 ↗

Auf einen Blick

Die Übersicht zu Biomarkern bei post-stroke cognitive impairment zeigt: Bildgebungsmarker waren konsistent mit PSCI assoziiert, Blutmarker lieferten variablere Ergebnisse.

Fragestellung

Welche Biomarker sind mit post-stroke cognitive impairment (PSCI) und post-stroke dementia assoziiert?

Methode

Systematische Übersicht von Beobachtungs- und Interventionsstudien zu Biomarkern bei akutem ischämischem oder hämorrhagischem Schlaganfall; PRISMA-basiert.

Ergebnisse

154 Studien mit n = 114.474: 99 Kohorten-, 19 Fall-Kontroll-, 35 Querschnitts- und 1 Interventionsstudie. Bildgebungsmarker zeigten konsistente, Blutmarker variablere Assoziationen mit PSCI.

Einschränkungen

Große Heterogenität bei Probenzeitpunkt, kognitiven Tests und Population; fehlende Standardisierung; residuale Confounding-Effekte.

Schlussfolgerung der Autor:innen

Mehrere körperflüssigkeitsbasierte, genetische und bildgebende Biomarker zeigen Potenzial für die Vorhersage von PSCI. Die klinische Nutzbarkeit bleibt jedoch durch Heterogenität und fehlende Standardisierung begrenzt.

Kernaussagen

  • Bildgebungsmarker wie Infarktvolumen, Atrophie und WMH waren konsistent assoziiert.
  • Blutmarker zeigten variable Ergebnisse und sind klinisch weniger gut nutzbar.
  • Genetische Marker zeigten eine moderate Evidenz für eine Assoziation mit PSCI.

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Systematische Übersicht in der Zeitschrift Frontiers in Behavioral Neuroscience, online erschienen am 22.06.2026. Verfasst von Lars Schmidli und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Stroke Center, University Hospital Basel, Basel, Switzerland. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Post-stroke cognitive impairment (PSCI) severely affects quality of life and prognosis in stroke survivors, yet reliable predictive, diagnostic and prognostic tools remain limited. Recent advances suggest that molecular, genetic, and imaging-based biomarkers may improve prediction and management of PSCI. The purpose of this systematic review was to provide a synthesis of the current evidence on biomarkers related to PSCI, aiming to highlight knowledge gaps and future research directions.

Methods

We conducted a systematic review of observational cohort, cross-sectional, case-control and interventional studies investigating biomarkers associated with PSCI and post-stroke dementia. Eligible studies enrolled patients with acute ischemic or hemorrhagic stroke and reported cognitive outcomes with biomarker assessments in blood, or other body fluids, or neuroimaging. Screening followed PRISMA guidelines. Data extraction included study design, population characteristics, biomarkers, and cognitive outcomes. Biomarkers were clustered by type for evidence synthesis.

Results

Of 834 screened studies, 154 were included (99 cohorts, 19 case-control, 35 cross-sectional, 1 interventional; n = 114,474). The most frequently studied biomarkers were imaging biomarkers, such as infarct volume, brain atrophy, and white matter hyperintensities, which showed consistent associations with PSCI, whereas blood-based biomarkers, notably markers of inflammation (e.g., CRP, IL-6), metabolism (e.g., HbA1c, homocysteine), and neuronal damage (e.g., amyloid-β 1–42 , plasma neurofilament light chain), yielded more variable results, thereby limiting their applicability in clinical practice. Genetic markers (e.g., related to APOE ε4, MMP-9, microRNAs) showed moderate evidence of association with PSCI. We found substantial heterogeneity in timing of sampling or acquisition, cognitive assessment tools and population characteristics.

Conclusion

Several body-fluid-based, genetic, and imaging biomarkers demonstrate potential for the prediction of PSCI. However, clinical utility remains constrained by study heterogeneity, lack of standardization and residual confounding. Standardized protocols for cognitive assessments and biomarker timing, as well as multi-center longitudinal studies, are essential to validate and translate these biomarkers into routine clinical care. Systematic review registration https://www.crd.york.ac.uk/PROSPERO/view/CRD42025642710 , identifier CRD42025642710.

Schlagwörter

Stichwörter der Autor:innen

biomarkersdementiainflammationmetabolismneuroimagingpost-stroke cognitive impairmentsmall vessel disease

Autor:innen und Institutionen

  • Department of Neurology and Stroke Center, University Hospital Basel, Basel, Switzerland.
  • Department of Neurology, Hannover Medical School, Hannover, Germany.
  • Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Barcelona, Spain.
  • University College Dublin School of Medicine, Dublin, Ireland.
  • Stroke Service, Department of Geriatric Medicine, Mater Misericordiae University Hospital, Dublin, Ireland.
  • Institute for Stroke and Dementia Research, University Hospital, LMU Munich, Munich, Germany.

Zitieren

APA

Schmidli, L., Richter, I., Thaliyath, S., Frenger, J., Zietz, A., Teller, J., Schuppner, R., Ernst, J., Gabriel, M. M., Camps-Renom, P., McCabe, J., Tiedt, S., Johansen, M. C., Katan, M., & Grosse, G. M. (2026). Biomarkers of post-stroke cognitive impairment—a systematic literature review. Frontiers in Behavioral Neuroscience, 20. https://doi.org/10.3389/fnbeh.2026.1864277

Vancouver

Schmidli L, Richter I, Thaliyath S, Frenger J, Zietz A, Teller J, et al. Biomarkers of post-stroke cognitive impairment—a systematic literature review. Frontiers in Behavioral Neuroscience. 2026;20. doi:10.3389/fnbeh.2026.1864277

BibTeX
@article{Schmidli2026,
  author = {Schmidli, Lars and Richter, Ines and Thaliyath, Shilpa and Frenger, Johannes and Zietz, Annaelle and Teller, Johannes and Schuppner, Ramona and Ernst, Johanna and Gabriel, Maria M and Camps-Renom, Pol and McCabe, John and Tiedt, Steffen and Johansen, Michelle C and Katan, Mira and Grosse, Gerrit M},
  title = {Biomarkers of post-stroke cognitive impairment—a systematic literature review},
  journal = {Frontiers in Behavioral Neuroscience},
  year = {2026},
  volume = {20},
  doi = {10.3389/fnbeh.2026.1864277}
}
Kostenlos starten →